| UNITEDHEALTH GROUP INC (UNH) | $447.57B | 2.7% | 25.4× | $355.72B |
| MCKESSON CORP (MCK) | $403.43B | 1.2% | 23.7× | $105.72B |
| CVS HEALTH Corp (CVS) | $402.07B | 0.4% | 24.8× | $124.83B |
| Cencora, Inc. (COR) | $321.33B | 0.5% | 24.0× | $63.16B |
| Cigna Group (CI) | $274.90B | 2.2% | 11.4× | $74.80B |
| CENTENE CORP (CNC) | $174.58B | -3.8% | — | $32.22B |
| HUMANA INC (HUM) | $129.66B | 0.9% | 36.2× | $47.42B |
| JOHNSON & JOHNSON (JNJ) | $94.19B | 28.5% | 30.9× | $653.54B |
| HCA Healthcare, Inc. (HCA) | $75.60B | 9.0% | 13.9× | $89.54B |
| ELI LILLY & Co (LLY) | $65.18B | 31.7% | 38.9× | $1.03T |
| Merck & Co., Inc. (MRK) | $65.01B | 28.1% | 118.0× | $369.73B |
| PFIZER INC (PFE) | $62.58B | 12.4% | 37.6× | $162.73B |
| AbbVie Inc. (ABBV) | $61.16B | 6.9% | 72.4× | $459.43B |
| BRISTOL MYERS SQUIBB CO (BMY) | $48.19B | 14.6% | 14.7× | $136.70B |
| THERMO FISHER SCIENTIFIC INC. (TMO) | $44.56B | 15.0% | 33.2× | $222.03B |
| ABBOTT LABORATORIES (ABT) | $44.33B | 14.7% | 35.3× | $188.49B |
| AMGEN INC (AMGN) | $36.75B | 21.0% | 27.2× | $236.86B |
| Medtronic plc (MDT) | $36.36B | 13.2% | 24.3× | $117.81B |
| GILEAD SCIENCES, INC. (GILD) | $29.44B | 28.9% | 22.1× | $185.89B |
| Medline Inc. (MDLN) | $28.43B | 4.1% | 43.9× | $47.24B |
| STRYKER CORP (SYK) | $25.12B | 12.9% | 33.6× | $121.75B |
| 3M CO (MMM) | $24.95B | 13.0% | 30.2× | $87.80B |
| DANAHER CORP /DE/ (DHR) | $24.57B | 14.7% | 38.0× | $145.47B |
| BECTON DICKINSON & CO (BDX) | $21.84B | 7.7% | 32.6× | $50.97B |
| TENET HEALTHCARE CORP (THC) | $21.31B | 11.1% | 10.3× | $21.56B |
| GE HealthCare Technologies Inc. (GEHC) | $20.63B | 10.1% | 16.4× | $31.81B |
| BOSTON SCIENTIFIC CORP (BSX) | $20.07B | 14.4% | 19.5× | $69.68B |
| UNIVERSAL HEALTH SERVICES INC (UHS) | $17.36B | 8.6% | 7.0× | $10.06B |
| TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | $17.26B | 8.2% | 60.3× | $42.17B |
| IQVIA HOLDINGS INC. (IQV) | $16.31B | 8.3% | 32.5× | $42.52B |
| REGENERON PHARMACEUTICALS, INC. (REGN) | $14.34B | 31.4% | 19.8× | $84.82B |
| Viatris Inc (VTRS) | $14.25B | -24.7% | — | $19.40B |
| LABCORP HOLDINGS INC. (LH) | $13.95B | 6.3% | 27.6× | $26.57B |
| DAVITA INC. (DVA) | $13.64B | 5.5% | 15.3× | $11.23B |
| BrightSpring Health Services, Inc. (BTSG) | $12.91B | 1.5% | 52.1× | $11.56B |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | $12.48B | 4.1% | 1.6× | $411.7M |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | $12.00B | 32.9% | 31.7× | $138.81B |
| BAXTER INTERNATIONAL INC (BAX) | $11.24B | -8.5% | — | $13.44B |
| QUEST DIAGNOSTICS INC (DGX) | $11.04B | 9.0% | 25.5× | $26.07B |
| Bausch Health Companies Inc. (BHC) | $10.27B | 1.5% | 15.2× | $2.38B |
| INTUITIVE SURGICAL INC (ISRG) | $10.06B | 28.4% | 43.3× | $132.29B |
| BIOGEN INC. (BIIB) | $9.89B | 13.1% | 38.4× | $31.92B |
| Zoetis Inc. (ZTS) | $9.47B | 28.2% | 12.6× | $31.92B |
| ROCKWELL AUTOMATION, INC (ROK) | $8.34B | 10.4% | 39.0× | $46.46B |
| Solventum Corp (SOLV) | $8.32B | 18.7% | 11.1× | $15.48B |
| ICON PLC (ICLR) | $8.25B | 2.8% | 256.0× | $13.03B |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | $8.23B | 8.6% | 24.1× | $18.97B |
| AGILENT TECHNOLOGIES, INC. (A) | $6.95B | 18.8% | 29.6× | $42.28B |
| Avantor, Inc. (AVTR) | $6.55B | -8.1% | — | $9.83B |
| Ardent Health, Inc. (ARDT) | $6.32B | 2.1% | 20.0× | $1.53B |
| Organon & Co. (OGN) | $6.22B | 3.0% | 17.7× | $3.62B |
| Edwards Lifesciences Corp (EW) | $6.07B | 17.7% | 54.0× | $52.30B |
| STERIS plc (STE) | $5.94B | 13.2% | 28.0× | $22.39B |
| Encompass Health Corp (EHC) | $5.94B | 9.5% | 20.0× | $11.92B |
| agilon health, inc. (AGL) | $5.93B | -6.6% | — | $1.58B |
| RESMED INC (RMD) | $5.65B | 26.9% | 22.2× | $33.37B |
| Option Care Health, Inc. (OPCH) | $5.65B | 3.7% | 17.9× | $3.60B |
| SELECT MEDICAL HOLDINGS CORP (SEM) | $5.45B | 2.7% | 15.4× | $2.05B |
| BeOne Medicines Ltd. (ONC) | $5.34B | 5.4% | 64.4× | $40.57B |
| PACS Group, Inc. (PACS) | $5.29B | 3.6% | 25.7× | $7.03B |
| INCYTE CORP (INCY) | $5.14B | 25.0% | 15.7× | $25.34B |
| Bausch & Lomb Corp (BLCO) | $5.10B | -7.1% | — | $6.24B |
| ENSIGN GROUP, INC (ENSG) | $5.03B | 6.8% | 28.4× | $10.53B |
| Elanco Animal Health Inc (ELAN) | $4.71B | -4.9% | — | $12.53B |
| DEXCOM INC (DXCM) | $4.66B | 17.9% | 35.6× | $34.02B |
| ILLUMINA, INC. (ILMN) | $4.34B | 19.6% | 39.8× | $31.28B |
| IDEXX LABORATORIES INC /DE (IDXX) | $4.30B | 24.6% | 39.1× | $42.95B |
| Jazz Pharmaceuticals plc (JAZZ) | $4.27B | -8.3% | — | $16.18B |
| PERRIGO Co plc (PRGO) | $4.25B | -33.5% | — | $1.99B |
| COOPER COMPANIES, INC. (COO) | $4.09B | 9.2% | 61.6× | — |
| ALIGN TECHNOLOGY INC (ALGN) | $4.03B | 10.2% | 27.4× | $11.19B |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $4.03B | 21.6% | 31.6× | $27.57B |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | $4.02B | -3.6% | — | $14.21B |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | $3.71B | 8.4% | 43.0× | $32.93B |
| DENTSPLY SIRONA Inc. (XRAY) | $3.68B | -16.3% | — | $2.23B |
| TRIMBLE INC. (TRMB) | $3.59B | 11.8% | 35.0× | $14.35B |
| BRUKER CORP (BRKR) | $3.44B | -0.3% | — | $8.54B |
| Acadia Healthcare Company, Inc. (ACHC) | $3.31B | -33.3% | — | $2.63B |
| Surgery Partners, Inc. (SGRY) | $3.31B | -2.4% | — | $1.82B |
| AdaptHealth Corp. (AHCO) | $3.24B | -2.2% | — | $773.8M |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | $3.22B | 10.8% | 177.3× | $12.70B |
| Brookdale Senior Living Inc. (BKD) | $3.19B | -8.2% | — | $2.91B |
| UNITED THERAPEUTICS Corp (UTHR) | $3.18B | 41.9% | 18.3× | $21.99B |
| WATERS CORP /DE/ (WAT) | $3.17B | 20.3% | 103.0× | $39.85B |
| MiniMed Group, Inc. (MMED) | $3.10B | -10.7% | — | $5.49B |
| WEST PHARMACEUTICAL SERVICES INC (WST) | $3.07B | 16.1% | 43.4× | $23.83B |
| Amneal Pharmaceuticals, Inc. (AMRX) | $3.02B | 2.4% | 36.5× | $6.11B |
| GLOBUS MEDICAL INC (GMED) | $2.94B | 18.3% | 21.3× | $11.16B |
| NEUROCRINE BIOSCIENCES INC (NBIX) | $2.86B | 16.7% | 22.8× | $15.85B |
| REVVITY, INC. (RVTY) | $2.86B | 8.4% | 62.2× | $14.37B |
| QuidelOrtho Corp (QDEL) | $2.73B | -41.5% | — | $1.05B |
| Fortrea Holdings Inc. (FTRE) | $2.72B | -36.2% | — | $1.76B |
| Envista Holdings Corp (NVST) | $2.72B | 1.7% | 47.3× | $4.41B |
| INSULET CORP (PODD) | $2.71B | 9.1% | 27.2× | $10.07B |
| BIO-RAD LABORATORIES, INC. (BIO) | $2.58B | 29.4% | 46.3× | $10.19B |
| Medpace Holdings, Inc. (MEDP) | $2.53B | 17.8% | 35.9× | $17.07B |
| CHEMED CORP (CHE) | $2.53B | 10.5% | 27.4× | $7.17B |
| Teladoc Health, Inc. (TDOC) | $2.53B | -7.9% | — | $1.18B |
| Aveanna Healthcare Holdings, Inc. (AVAH) | $2.43B | 9.2% | 10.8× | $2.97B |
| Royalty Pharma plc (RPRX) | $2.38B | 32.4% | 33.5× | $36.01B |
| Hims & Hers Health, Inc. (HIMS) | $2.35B | 5.5% | 55.8× | $6.64B |
| EXELIXIS, INC. (EXEL) | $2.32B | 33.7% | 17.8× | $13.90B |
| Natera, Inc. (NTRA) | $2.31B | -9.0% | — | $46.24B |
| Enovis CORP (ENOV) | $2.25B | -52.7% | — | $1.46B |
| ICU MEDICAL INC/DE (ICUI) | $2.23B | 0.0% | 148.4× | $4.38B |
| Sarepta Therapeutics, Inc. (SRPT) | $2.20B | -32.5% | — | $2.20B |
| Concentra Group Holdings Parent, Inc. (CON) | $2.16B | 7.7% | 22.4× | $4.42B |
| Privia Health Group, Inc. (PRVA) | $2.12B | 1.1% | 94.5× | $2.66B |
| QIAGEN N.V. (QGEN) | $2.09B | 20.3% | 21.9× | $8.90B |
| RadNet, Inc. (RDNT) | $2.04B | -0.9% | — | $5.87B |
| TELEFLEX INC (TFX) | $1.99B | -45.4% | — | $5.92B |
| National Vision Holdings, Inc. (EYE) | $1.99B | 1.5% | 28.8× | $1.41B |
| Moderna, Inc. (MRNA) | $1.94B | — | — | $61.59B |
| Pediatrix Medical Group, Inc. (MD) | $1.91B | 8.6% | 12.7× | $2.16B |
| MSA Safety Inc (MSA) | $1.87B | 14.9% | 23.7× | $7.34B |
| Integer Holdings Corp (ITGR) | $1.85B | 5.5% | 34.3× | $4.26B |
| HEALTHCARE SERVICES GROUP INC (HCSG) | $1.84B | 3.2% | 13.1× | $1.54B |
| PTC THERAPEUTICS, INC. (PTCT) | $1.73B | 39.4% | 9.0× | $5.85B |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | $1.64B | -31.6% | — | $1.31B |
| Lantheus Holdings, Inc. (LNTH) | $1.54B | 15.2% | 24.1× | $6.58B |
| MASIMO CORP (MASI) | $1.53B | -9.9% | — | — |
| PHIBRO ANIMAL HEALTH CORP (PAHC) | $1.52B | 6.6% | 15.5× | $1.56B |
| MERIT MEDICAL SYSTEMS INC (MMSI) | $1.52B | 8.5% | 37.2× | $5.40B |
| Alkermes plc. (ALKS) | $1.48B | 16.4% | 124.8× | $7.95B |
| NATIONAL HEALTHCARE CORP (NHC) | $1.47B | 8.2% | 25.1× | $3.49B |
| P3 Health Partners Inc. (PIII) | $1.46B | -10.1% | — | $1.78B |
| LifeStance Health Group, Inc. (LFST) | $1.42B | 0.7% | 94.7× | $4.70B |
| Addus HomeCare Corp (ADUS) | $1.42B | 6.7% | 20.2× | $2.16B |
| Penumbra Inc (PEN) | $1.40B | 12.7% | 78.8× | $12.67B |
| HALOZYME THERAPEUTICS, INC. (HALO) | $1.40B | 22.7% | 30.9× | $11.96B |
| LivaNova PLC (LIVN) | $1.39B | -17.5% | — | $4.41B |
| CONMED Corp (CNMD) | $1.37B | 3.4% | 27.2× | $1.51B |
| HAEMONETICS CORP (HAE) | $1.33B | 7.3% | 51.0× | $4.73B |
| Progyny, Inc. (PGNY) | $1.29B | 4.5% | 28.3× | $1.99B |
| Curaleaf Holdings, Inc. (CURLF) | $1.27B | -18.2% | — | $2.48B |
| Indivior Pharmaceuticals, Inc. (INDV) | $1.24B | 16.9% | 12.5× | $4.12B |
| Nasus Pharma Ltd (NSRX) | $1.24B | -0.5% | — | $48.0M |
| BIO-TECHNE Corp (TECH) | $1.22B | 15.0% | 62.4× | $11.35B |
| Trulieve Cannabis Corp. (TRLV) | $1.18B | -9.9% | — | $2.26B |
| Sotera Health Co (SHC) | $1.16B | 6.7% | 34.4× | $5.50B |
| NOVAVAX INC (NVAX) | $1.12B | 39.2% | 3.6× | $1.53B |
| Prestige Consumer Healthcare Inc. (PBH) | $1.09B | 17.5% | 14.7× | $2.49B |
| Embecta Corp. (EMBC) | $1.08B | 8.8% | 3.4× | $286.1M |
| ACADIA PHARMACEUTICALS INC (ACAD) | $1.07B | 36.5% | 13.1× | $5.02B |
| TANDEM DIABETES CARE INC (TNDM) | $1.01B | -20.2% | — | $1.49B |
| ONTO INNOVATION INC. (ONTO) | $1.01B | 13.6% | 101.0× | $16.55B |
| Guardant Health, Inc. (GH) | $982.0M | -42.4% | — | $22.06B |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | $958.4M | -30.1% | — | $12.33B |
| Pennant Group, Inc. (PNTG) | $947.7M | 3.1% | 40.7× | $1.30B |
| IONIS PHARMACEUTICALS INC (IONS) | $943.7M | -40.4% | — | $10.15B |
| Mirion Technologies, Inc. (MIR) | $925.4M | 3.1% | 172.3× | $3.86B |
| USANA HEALTH SCIENCES INC (USNA) | $925.3M | 1.2% | 24.6× | $263.5M |
| Tilray Brands, Inc. (TLRY) | $915.5M | -13.3% | — | $631.5M |
| Inspire Medical Systems, Inc. (INSP) | $912.0M | 15.9% | 13.6× | $1.78B |
| ANI PHARMACEUTICALS INC (ANIP) | $883.4M | 8.9% | 16.0× | $1.68B |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | $874.8M | 30.2% | 8.2× | $2.52B |
| Warby Parker Inc. (WRBY) | $871.9M | 0.2% | 403.2× | $2.99B |
| NEOGEN CORP (NEOG) | $870.4M | -0.9% | — | $2.54B |
| Harmony Biosciences Holdings, Inc. (HRMY) | $868.5M | 18.3% | 12.7× | $2.28B |
| InnovAge Holding Corp. (INNV) | $853.7M | -3.6% | — | $1.47B |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | $829.4M | -0.2% | — | $12.51B |
| MYRIAD GENETICS INC (MYGN) | $824.5M | -44.4% | — | $302.3M |
| Orthofix Medical Inc. (OFIX) | $822.3M | -11.2% | — | $392.1M |
| Caris Life Sciences, Inc. (CAI) | $812.0M | -8.4% | — | $7.25B |
| U S PHYSICAL THERAPY INC /NV (USPH) | $781.0M | 5.1% | 457.3× | $1.16B |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | $780.6M | 8.1% | 20.0× | $785.8M |
| Alphatec Holdings, Inc. (ATEC) | $764.2M | -18.8% | — | $1.48B |
| CORCEPT THERAPEUTICS INC (CORT) | $761.4M | 13.1% | 258.8× | $12.31B |
| iRhythm Holdings, Inc. (IRTC) | $747.1M | -6.0% | — | $3.96B |
| Emergent BioSolutions Inc. (EBS) | $742.9M | 7.1% | 6.4× | $303.0M |
| REPLIGEN CORP (RGEN) | $738.3M | 6.6% | 244.8× | $9.95B |
| Pacira BioSciences, Inc. (PCRX) | $726.4M | 1.0% | 73.6× | $1.03B |
| Amphastar Pharmaceuticals, Inc. (AMPH) | $719.9M | 13.6% | 13.3× | $976.7M |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | $719.0M | -5.4% | — | $2.54B |
| AVANOS MEDICAL, INC. (AVNS) | $701.2M | -10.4% | — | $1.17B |
| Kiniksa Pharmaceuticals International, plc (KNSA) | $677.6M | 8.7% | 80.1× | $6.19B |
| Ultragenyx Pharmaceutical Inc. (RARE) | $673.0M | -85.4% | — | $2.52B |
| Cresco Labs Inc. (CRLBF) | $655.8M | -20.6% | — | $287.8M |
| NovoCure Ltd (NVCR) | $655.4M | -20.8% | — | $2.08B |
| 10x Genomics, Inc. (TXG) | $642.8M | -6.8% | — | $7.81B |
| Axsome Therapeutics, Inc. (AXSM) | $638.5M | -28.7% | — | $10.42B |
| TG THERAPEUTICS, INC. (TGTX) | $616.3M | 72.6% | 19.7× | $8.26B |
| Cadre Holdings, Inc. (CDRE) | $610.3M | 7.2% | 38.0× | $1.32B |
| OPKO HEALTH, INC. (OPK) | $606.9M | -37.2% | — | $1.10B |
| INSMED Inc (INSM) | $606.4M | — | — | $26.54B |
| TransMedics Group, Inc. (TMDX) | $605.5M | 31.4% | 22.9× | $3.07B |
| UFP TECHNOLOGIES INC (UFPT) | $602.8M | 11.3% | 32.5× | $2.31B |
| CATALYST PHARMACEUTICALS, INC. (CPRX) | $589.0M | 36.4% | 18.2× | $3.85B |
| Bioventus Inc. (BVS) | $568.1M | 4.0% | 17.5× | $933.7M |
| Organogenesis Holdings Inc. (ORGO) | $564.2M | 6.6% | 11.5× | $221.3M |
| HUTCHMED (China) Ltd (HCM) | $548.5M | 83.3% | 123.8× | $2.15B |
| AtriCure, Inc. (ATRC) | $534.5M | -2.1% | — | $2.47B |
| Mirum Pharmaceuticals, Inc. (MIRM) | $521.3M | -4.5% | — | $5.98B |
| VERACYTE, INC. (VCYT) | $517.1M | 12.8% | 30.9× | $3.47B |
| Inotiv, Inc. (NOTVQ) | $513.0M | -13.4% | — | $390,419 |
| ADMA BIOLOGICS, INC. (ADMA) | $510.2M | 28.8% | 13.3× | $2.09B |
| GLAUKOS Corp (GKOS) | $507.4M | -37.0% | — | $10.59B |
| Starling Oncology, Inc. (STLN) | $502.7M | -12.1% | — | $602.3M |
| BridgeBio Pharma, Inc. (BBIO) | $502.1M | — | — | $14.97B |
| Ascend Wellness Holdings, Inc. (AAWH) | $500.6M | -23.6% | — | $80.3M |
| Travere Therapeutics, Inc. (TVTX) | $490.7M | -5.2% | — | $6.25B |
| NATURES SUNSHINE PRODUCTS INC (NATR) | $480.1M | 4.1% | 14.2× | $249.0M |
| Ayr Wellness Inc. (AYRWF) | $463.6M | -77.5% | — | $432,062 |
| Zai Lab Ltd (ZLAB) | $457.2M | -38.4% | — | $2.84B |
| Tarsus Pharmaceuticals, Inc. (TARS) | $451.4M | -14.7% | — | $3.26B |
| ARTIVION, INC. (AORT) | $441.3M | 2.2% | 129.0× | $1.32B |
| GeneDx Holdings Corp. (WGS) | $427.5M | -4.9% | — | $2.53B |
| MIMEDX GROUP, INC. (MDXG) | $418.6M | 11.6% | 113.5× | $661.8M |
| Innoviva, Inc. (INVA) | $411.3M | 65.9% | 4.8× | $1.50B |
| ARDELYX, INC. (ARDX) | $407.3M | -15.1% | — | $970.8M |
| Esperion Therapeutics, Inc. (ESPR) | $403.1M | -5.6% | — | $819.5M |
| ACCURAY INC (ARAY) | $401.9M | -12.2% | — | $30.4M |
| Immunocore Holdings plc (IMCR) | $400.0M | -8.9% | — | $1.87B |
| Krystal Biotech, Inc. (KRYS) | $389.1M | 52.6% | 45.0× | $10.64B |
| SINOVAC BIOTECH LTD (SVA) | $386.0M | -51.5% | — | — |
| SONIDA SENIOR LIVING, INC. (SNDA) | $381.1M | -18.6% | — | $1.80B |
| CareDx, Inc. (CDNA) | $379.8M | -5.6% | — | $2.58B |
| Twist Bioscience Corp (TWST) | $376.6M | -20.6% | — | $9.15B |
| Arcutis Biotherapeutics, Inc. (ARQT) | $372.1M | -4.3% | — | $2.99B |
| InMode Ltd. (INMD) | $370.5M | 25.3% | 12.4× | $860.9M |
| MANNKIND CORP (MNKD) | $349.0M | 1.7% | 200.5× | $1.29B |
| CASTLE BIOSCIENCES INC (CSTL) | $344.2M | -7.0% | — | $1.01B |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | $329.5M | 5.8% | 21.5× | $520.5M |
| Fulgent Genetics, Inc. (FLGT) | $322.7M | -18.8% | — | $533.0M |
| DocGo Inc. (DCGO) | $322.2M | -56.6% | — | $39.3M |
| ANGIODYNAMICS INC (ANGO) | $320.2M | -11.5% | — | $655.1M |
| CorMedix Inc. (CRMD) | $311.7M | 52.3% | 3.8× | $643.8M |
| PROCEPT BioRobotics Corp (PRCT) | $308.1M | -31.0% | — | $1.21B |
| BillionToOne, Inc. (BLLN) | $305.1M | 2.4% | 126.5× | $4.36B |
| SkinHealth Systems Inc. (SKIN) | $300.8M | -3.2% | — | $88.0M |
| Evolus, Inc. (EOLS) | $297.2M | -17.4% | — | $600.4M |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | $296.2M | 8.1% | 5.4× | $702.3M |
| Inogen Inc (INGN) | $295.3M | -7.7% | — | $142.5M |
| RIGEL PHARMACEUTICALS INC (RIGL) | $294.3M | — | 2.7× | $862.6M |
| Xeris Biopharma Holdings, Inc. (XERS) | $291.8M | 0.2% | — | $1.54B |
| Aurinia Pharmaceuticals Inc. (AUPH) | $283.1M | — | 7.1× | $2.17B |
| Adaptive Biotechnologies Corp (ADPT) | $277.0M | -21.5% | — | $3.98B |
| Vericel Corp (VCEL) | $276.3M | 6.0% | 90.3× | $2.17B |
| HARROW, INC. (HROW) | $272.3M | -1.9% | — | $1.38B |
| VIEMED HEALTHCARE, INC. (VMD) | $270.3M | 5.5% | 25.9× | $355.4M |
| Vireo Growth Inc. (VREOF) | $268.8M | -25.3% | — | $557.1M |
| LIGAND PHARMACEUTICALS INC (LGND) | $268.1M | 46.4% | 29.0× | $5.74B |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | $263.5M | — | — | $3.70B |
| Jushi Holdings Inc. (JUSH) | $262.9M | -26.1% | — | $82.3M |
| ARVINAS, INC. (ARVN) | $262.6M | -30.8% | — | $592.3M |
| Omada Health, Inc. (OMDA) | $260.2M | -4.9% | — | $1.47B |
| Schrodinger, Inc. (SDGR) | $255.9M | -40.4% | — | $1.56B |
| LEMAITRE VASCULAR INC (LMAT) | $249.6M | 23.1% | 27.5× | $1.82B |
| Arcus Biosciences, Inc. (RCUS) | $247.0M | — | — | $3.87B |
| Keros Therapeutics, Inc. (KROS) | $243.9M | 35.7% | 4.8× | $220.5M |
| STAAR SURGICAL CO (STAA) | $239.4M | -33.6% | — | $1.13B |
| Vaxart, Inc. (VXRT) | $237.3M | 6.9% | 2.9× | $121.6M |
| ORTHOPEDIATRICS CORP (KIDS) | $236.3M | -16.8% | — | $627.4M |
| Akebia Therapeutics, Inc. (AKBA) | $236.2M | -2.3% | — | $254.6M |
| ANAPTYSBIO, INC (ANAB) | $234.6M | -5.6% | — | $1.67B |
| CERUS CORP (CERS) | $233.8M | -6.7% | — | $534.0M |
| Talkspace, Inc. (TALK) | $228.9M | 3.4% | 131.3× | $870.6M |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | $228.4M | 13.6% | 18.3× | $472.8M |
| Axogen, Inc. (AXGN) | $225.2M | -7.0% | — | $2.77B |
| IDEAYA Biosciences, Inc. (IDYA) | $218.7M | -52.0% | — | $4.03B |
| Vanda Pharmaceuticals Inc. (VNDA) | $216.1M | — | — | $319.8M |
| AMARIN CORP PLC\UK (AMRN) | $213.6M | -18.2% | — | $295.1M |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | $212.7M | -27.7% | — | $302.4M |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $211.1M | -24.2% | — | $2.14B |
| Cytek Biosciences, Inc. (CTKB) | $201.5M | -33.0% | — | $594.0M |
| SI-BONE, Inc. (SIBN) | $200.9M | -9.4% | — | $861.0M |
| Strata Critical Medical, Inc. (SRTA) | $197.1M | 21.0% | 11.9× | $528.1M |
| LifeMD, Inc. (LFMD) | $194.1M | 7.4% | 13.0× | $157.1M |
| LAKELAND INDUSTRIES INC (LAKE) | $192.6M | -13.1% | — | $117.9M |
| biote Corp. (BTMD) | $192.2M | 14.1% | 11.9× | $56.6M |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | $189.8M | — | — | $7.38B |
| MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) | $185.7M | -70.4% | — | $2.70B |
| Stoke Therapeutics, Inc. (STOK) | $184.4M | -3.7% | — | $2.04B |
| Lifevantage Corp (LFVN) | $182.6M | 2.8% | 14.3× | $81.4M |
| Glass House Brands Inc. (GLAS) | $182.0M | -16.3% | — | $921.7M |
| Adaptimmune Therapeutics PLC (ADAPY) | $178.0M | -39.8% | — | $7.2M |
| Cryoport, Inc. (CYRX) | $176.2M | 44.4% | 11.8× | $839.3M |
| Heartflow, Inc. (HTFL) | $176.0M | -66.3% | — | $4.18B |
| Phathom Pharmaceuticals, Inc. (PHAT) | $175.1M | — | — | $723.3M |
| SBC Medical Group Holdings Inc (SBC) | $173.6M | 29.4% | 8.4× | $416.5M |
| Syndax Pharmaceuticals Inc (SNDX) | $172.4M | — | — | $1.74B |
| REGENXBIO Inc. (RGNX) | $170.4M | — | — | $637.7M |
| Ginkgo Bioworks Holdings, Inc. (DNA) | $170.2M | — | — | $466.7M |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | $160.0M | — | — | $481.8M |
| MARIMED INC. (MRMD) | $159.8M | -9.1% | — | $35.9M |
| Liquidia Corp (LQDA) | $158.3M | -43.5% | — | $6.26B |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | $154.9M | -13.0% | — | $63.0M |
| Airsculpt Technologies, Inc. (AIRS) | $151.8M | -7.7% | — | $187.4M |
| MACROGENICS INC (MGNX) | $149.5M | -49.9% | — | $259.9M |
| Neuronetics, Inc. (STIM) | $149.2M | -26.1% | — | $224.0M |
| ELITE PHARMACEUTICALS INC /NV/ (ELTP) | $148.9M | 30.1% | 5.8× | $312.4M |
| GRAIL, Inc. (GRAL) | $147.2M | — | — | $3.68B |
| Cronos Group Inc. (CRON) | $146.6M | -6.4% | — | $1.31B |
| Karyopharm Therapeutics Inc. (KPTI) | $146.1M | — | — | $44.0M |
| InfuSystem Holdings, Inc (INFU) | $143.4M | 4.6% | 30.2× | $240.2M |
| Beam Therapeutics Inc. (BEAM) | $139.7M | -57.2% | — | $3.03B |
| Quanterix Corp (QTRX) | $138.9M | -77.1% | — | $124.9M |
| NRC HEALTH (NRC) | $137.4M | 8.4% | 91.7× | $486.9M |
| RxSight, Inc. (RXST) | $134.5M | -29.0% | — | $293.2M |
| Xtant Medical Holdings, Inc. (XTNT) | $133.9M | 3.7% | 12.8× | $53.9M |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | $129.9M | -10.5% | — | $14.4M |
| Niagen Bioscience, Inc. (NAGE) | $129.4M | 13.4% | 16.9× | $254.0M |
| LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) | $128.9M | -30.0% | — | $171.9M |
| Xencor Inc (XNCR) | $125.6M | -73.2% | — | $1.94B |
| Monte Rosa Therapeutics, Inc. (GLUE) | $123.7M | -31.2% | — | $1.22B |
| Atara Biotherapeutics, Inc. (ATRA) | $120.8M | 27.1% | 3.6× | $94.2M |
| Outset Medical, Inc. (OM) | $119.5M | -68.3% | — | $76.9M |
| GYRE THERAPEUTICS, INC. (GYRE) | $116.6M | 8.5% | 334.0× | $708.3M |
| ORASURE TECHNOLOGIES INC (OSUR) | $115.0M | -59.8% | — | $247.6M |
| AGENUS INC (AGEN) | $114.2M | -2.7% | — | $351.5M |
| ImmunityBio, Inc. (IBRX) | $113.3M | — | — | $8.90B |
| Anika Therapeutics, Inc. (ANIK) | $112.8M | -9.6% | — | $279.3M |
| GEOSPACE TECHNOLOGIES CORP (GEOS) | $110.8M | -8.8% | — | $67.7M |
| UroGen Pharma Ltd. (URGN) | $109.8M | — | — | $2.13B |
| Century Therapeutics, Inc. (IPSC) | $109.2M | -8.8% | — | $403.8M |
| MANNATECH INC (MTEX) | $108.0M | -14.1% | — | $12.2M |
| Theravance Biopharma, Inc. (TBPH) | $107.5M | 98.5% | 16.4× | $885.2M |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | $106.5M | 78.2% | 12.4× | $686.8M |
| Zymeworks Inc. (ZYME) | $106.0M | -76.6% | — | $2.02B |
| Owlet, Inc. (OWLT) | $105.7M | -37.5% | — | $146.4M |
| Sanara MedTech Inc. (SMTI) | $103.1M | -36.4% | — | $317.6M |
| SUTRO BIOPHARMA, INC. (STRO) | $102.5M | — | — | $339.1M |
| Beta Bionics, Inc. (BBNX) | $100.3M | -73.0% | — | $870.1M |
| NeuroPace Inc (NPCE) | $100.0M | -21.5% | — | $485.0M |
| Butterfly Network, Inc. (BFLY) | $97.6M | -79.0% | — | $2.18B |
| BIOLIFE SOLUTIONS INC (BLFS) | $96.2M | -4.8% | — | $1.81B |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | $95.1M | — | — | $1.50B |
| SIGA TECHNOLOGIES INC (SIGA) | $94.6M | 24.6% | 9.6× | $219.9M |
| Pulmonx Corp (LUNG) | $90.5M | -59.7% | — | $103.9M |
| VASO Corp (VASO) | $89.1M | 1.8% | 29.0× | $51.0M |
| Ceribell, Inc. (CBLL) | $89.1M | -60.0% | — | $900.0M |
| BIODESIX INC (BDSX) | $88.5M | -39.8% | — | $322.9M |
| CYTOKINETICS INC (CYTK) | $88.0M | — | — | $11.01B |
| HARVARD BIOSCIENCE INC (HBIO) | $86.5M | -65.5% | — | $36.0M |
| LakeShore Biopharma Co., Ltd. (LSBCF) | $85.7M | -16.3% | — | — |
| STANDARD BIOTOOLS INC. (LAB) | $85.3M | -87.8% | — | $256.4M |
| DELCATH SYSTEMS, INC. (DCTH) | $85.2M | 3.2% | 1640.0× | $569.1M |
| 4D Molecular Therapeutics, Inc. (FDMT) | $85.2M | — | — | $792.8M |
| ARS Pharmaceuticals, Inc. (SPRY) | $84.3M | — | — | $585.7M |
| Nurix Therapeutics, Inc. (NRIX) | $84.0M | — | — | $2.79B |
| IRADIMED CORP (IRMD) | $83.8M | 26.8% | 48.6× | $1.11B |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $82.0M | -80.2% | — | $419.5M |
| FITLIFE BRANDS, INC. (FTLF) | $81.5M | 7.8% | 16.3× | $94.8M |
| MeiraGTx Holdings plc (MGTX) | $81.4M | — | — | $1.36B |
| ADC Therapeutics SA (ADCT) | $81.4M | — | — | $158.3M |
| TELA Bio, Inc. (TELA) | $80.3M | -48.4% | — | $31.4M |
| Eton Pharmaceuticals, Inc. (ETON) | $80.0M | -5.8% | — | $1.79B |
| Sight Sciences, Inc. (SGHT) | $77.4M | -49.7% | — | $471.0M |
| Burning Rock Biotech Ltd (BNR) | $77.2M | -10.3% | — | $97.2M |
| CytomX Therapeutics, Inc. (CTMX) | $76.2M | -22.8% | — | $723.4M |
| Autolus Therapeutics plc (AUTL) | $75.4M | — | — | $620.2M |
| AbCellera Biologics Inc. (ABCL) | $75.1M | — | — | $3.66B |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | $74.7M | — | — | $1.79B |
| Electromed, Inc. (ELMD) | $73.8M | 15.3% | 23.2× | $252.2M |
| COMPUGEN LTD (CGEN) | $72.8M | 48.6% | 7.5× | $269.0M |
| BICYCLE THERAPEUTICS PLC (BCYC) | $72.6M | — | — | $304.8M |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | $72.3M | -8.5% | — | $716.3M |
| AVITA Medical, Inc. (RCEL) | $70.9M | -68.5% | — | $320.1M |
| Viridian Therapeutics, Inc.\DE (VRDN) | $70.8M | — | — | $2.61B |
| EDAP TMS SA (FOCL) | $70.5M | -41.5% | — | $199.4M |
| Black Diamond Therapeutics, Inc. (BDTX) | $70.0M | 32.0% | 5.8× | $130.1M |
| Personalis, Inc. (PSNL) | $69.6M | — | — | $1.82B |
| ROCKWELL MEDICAL, INC. (RMTI) | $69.3M | -7.7% | — | $32.9M |
| Vir Biotechnology, Inc. (VIR) | $68.6M | — | — | $1.83B |
| Intellia Therapeutics, Inc. (NTLA) | $67.7M | — | — | $1.84B |
| Kura Oncology, Inc. (KURA) | $67.5M | — | — | $1.17B |
| Spero Therapeutics, Inc. (SPRO) | $66.8M | 12.8% | 8.6× | $69.9M |
| PRO DEX INC (PDEX) | $66.6M | 13.5% | 17.9× | $207.1M |
| EXAGEN INC. (XGN) | $66.6M | -30.0% | — | $179.0M |
| AYTU BIOPHARMA, INC (AYTU) | $66.4M | -20.4% | — | $24.7M |
| ENANTA PHARMACEUTICALS INC (ENTA) | $65.3M | — | — | $401.9M |
| Concord Medical Services Holdings Ltd (CCM) | $65.0M | -20.4% | — | $21.5M |
| Nuvation Bio Inc. (NUVB) | $62.9M | — | — | $2.34B |
| Tango Therapeutics, Inc. (TNGX) | $62.4M | — | — | $3.94B |
| Meihua International Medical Technologies Co., Ltd. (MHUAF) | $61.8M | 11.0% | — | $6.1M |
| Journey Medical Corp (DERM) | $61.2M | -18.7% | — | $213.7M |
| Fortress Biotech, Inc. (FBIO) | $61.2M | 11.1% | 1.0× | $89.4M |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | $59.4M | -2.0% | — | $68.4M |
| ALPHA PRO TECH LTD (APT) | $59.1M | 6.0% | 13.8× | $56.2M |
| CVRx, Inc. (CVRX) | $56.7M | -94.1% | — | $87.1M |
| 908 Devices Inc. (MASS) | $56.2M | 34.7% | 19.9× | $443.5M |
| NEKTAR THERAPEUTICS (NKTR) | $55.2M | — | — | $2.55B |
| INTEGRATED BIOPHARMA INC (INBP) | $54.4M | 1.5% | 6.3× | $5.9M |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | $54.0M | — | — | $1.99B |
| Q32 Bio Inc. (QTTB) | $53.7M | 55.5% | 4.8× | $447.4M |
| Invivyd, Inc. (IVVD) | $53.4M | -98.2% | — | $265.3M |
| Apyx Medical Corp (APYX) | $52.8M | -21.2% | — | $128.5M |
| Protalix BioTherapeutics, Inc. (PLX) | $52.7M | -12.5% | — | $204.7M |
| IRIDEX CORP (IRIX) | $52.7M | -8.4% | — | $12.4M |
| XOMA Royalty Corp (XOMA) | $52.1M | 60.8% | 25.6× | $710.2M |
| OCULAR THERAPEUTIX, INC (OCUL) | $52.0M | — | — | $2.38B |
| LENSAR, Inc. (LNSR) | $51.7M | -66.4% | — | $102.0M |
| CARLSMED, INC. (CARL) | $50.5M | -58.7% | — | $441.8M |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | $49.8M | — | — | $1.02B |
| Gossamer Bio, Inc. (GOSS) | $48.5M | — | — | $83.2M |
| SHOULDER INNOVATIONS, INC. (SI) | $47.3M | -85.3% | — | $440.5M |
| Protagonist Therapeutics, Inc (PTGX) | $46.0M | — | — | $9.56B |
| Septerna, Inc. (SEPN) | $46.0M | — | — | $1.82B |
| TriSalus Life Sciences, Inc. (TLSI) | $45.2M | -86.9% | — | $297.4M |
| FENNEC PHARMACEUTICALS INC. (FENC) | $44.6M | -21.8% | — | $412.7M |
| Aquestive Therapeutics, Inc. (AQST) | $44.5M | — | — | $641.4M |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | $44.5M | -6.4% | — | $134.4M |
| SANUWAVE Health, Inc. (SNWV) | $44.1M | 26.8% | 5.8× | $40.2M |
| Xilio Therapeutics, Inc. (XLO) | $43.8M | -80.1% | — | $59.2M |
| Wave Life Sciences, Inc. (WVE) | $42.7M | — | — | $993.1M |
| SS Innovations International, Inc. (SSII) | $42.5M | -28.5% | — | $697.3M |
| Coherus Oncology, Inc. (CHRS) | $42.2M | — | 1.0× | $224.0M |
| Biofrontera Inc. (BFRI) | $41.7M | -25.3% | — | $22.7M |
| KORU Medical Systems, Inc. (KRMD) | $41.1M | -6.4% | — | $148.4M |
| MYOMO, INC. (MYO) | $40.9M | -38.1% | — | $63.4M |
| Editas Medicine, Inc. (EDIT) | $40.5M | — | — | $506.8M |
| Alpha Teknova, Inc. (TKNO) | $40.5M | -42.6% | — | $382.3M |
| Voyager Therapeutics, Inc. (VYGR) | $40.4M | — | — | $213.2M |
| SANGAMO THERAPEUTICS, INC (SGMOQ) | $39.6M | — | — | $66.3M |
| Kymera Therapeutics, Inc. (KYMR) | $39.2M | — | — | $9.89B |
| INTERPACE BIOSCIENCES, INC. (IDXG) | $38.7M | 63.5% | 1.6× | $8.0M |
| UTAH MEDICAL PRODUCTS INC (UTMD) | $38.5M | 29.3% | 22.5× | $231.7M |
| RETRACTABLE TECHNOLOGIES INC (RVP) | $38.3M | -32.8% | — | $21.9M |
| BGM Group Ltd. (BGM) | $37.9M | -52.6% | — | $109.3M |
| Cytosorbents Corp (CTSO) | $37.1M | -22.1% | — | $22.6M |
| ClearPoint Neuro, Inc. (CLPT) | $37.0M | -69.1% | — | $499.4M |
| LFTD PARTNERS INC. (LIFD) | $36.9M | -67.3% | — | $1.5M |
| Sunshine Biopharma Inc. (SBFM) | $36.3M | -16.5% | — | $4.5M |
| C4 Therapeutics, Inc. (CCCC) | $35.9M | — | — | $521.6M |
| Earth Science Tech, Inc. (ETST) | $35.7M | 10.2% | 9.3× | $26.8M |
| Verrica Pharmaceuticals Inc. (VRCA) | $35.6M | -50.3% | — | $97.7M |
| X4 Pharmaceuticals, Inc (XFOR) | $35.1M | — | — | $400.6M |
| Leef Brands Inc. (LEEEF) | $34.8M | -50.7% | — | $60.5M |
| BIOHARVEST SCIENCES INC. (BHST) | $34.5M | -32.3% | — | $45.3M |
| PRECISION BIOSCIENCES INC (DTIL) | $34.3M | — | — | $231.9M |
| RAPID MICRO BIOSYSTEMS, INC. (RPID) | $33.6M | — | — | $75.2M |
| Orchestra BioMed Holdings, Inc. (OBIO) | $33.5M | — | — | $311.6M |
| MAXCYTE, INC. (MXCT) | $33.0M | — | — | $125.9M |
| C21 Investments Inc. (CXXIF) | $32.6M | -9.9% | — | $31.4M |
| Stereotaxis, Inc. (STXS) | $32.4M | -66.8% | — | $145.3M |
| electroCore, Inc. (ECOR) | $32.0M | -43.6% | — | $87.5M |
| Zomedica Corp. (ZOMDF) | $32.0M | — | — | $80.4M |
| Premier Air Charter Holdings Inc. (PREM) | $31.9M | -12.1% | — | $2.0M |
| Sonendo, Inc. (SONX) | $31.7M | -88.4% | — | $4.8M |
| CRYO CELL INTERNATIONAL INC (CCEL) | $31.6M | -7.7% | — | $34.3M |
| EyePoint, Inc. (EYPT) | $31.4M | — | — | $388.2M |
| Verastem, Inc. (VSTM) | $30.9M | — | — | $653.9M |
| Foghorn Therapeutics Inc. (FHTX) | $30.9M | — | — | $369.4M |
| STRATA Skin Sciences, Inc. (SSKN) | $30.7M | -20.4% | — | $29,441 |
| Synergy CHC Corp. (SNYR) | $30.4M | -40.6% | — | $1.5M |
| Scilex Holding Co (SCLX) | $30.3M | — | — | $38.2M |
| CapForce Inc. (CFOR) | $30.2M | 78.2% | 0.9× | $62.0M |
| Bionano Genomics, Inc. (BNGO) | $28.5M | -92.6% | — | $14.3M |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | $28.1M | -5.5% | — | $9.6M |
| IMMUCELL CORP /DE/ (ICCC) | $27.6M | -3.8% | — | $91.0M |
| Sensus Healthcare, Inc. (SRTS) | $27.5M | -28.1% | — | $57.9M |
| Cue Biopharma, Inc. (CUE) | $27.5M | -96.9% | — | $209.6M |
| Celularity Inc (CELU) | $26.6M | — | — | $25.5M |
| Entrada Therapeutics, Inc. (TRDA) | $25.4M | — | — | $272.6M |
| Metagenomi Therapeutics, Inc. (MGX) | $25.2M | — | — | $45.0M |
| CYANOTECH CORP (CYAN) | $24.2M | -13.2% | — | $3.3M |
| ALUMIS INC. (ALMS) | $24.1M | — | — | $2.82B |
| Precipio, Inc. (PRPO) | $24.0M | -1.5% | — | $51.6M |
| Baird Medical Investment Holdings Ltd (BDMD) | $22.5M | — | — | $37.7M |
| NewAmsterdam Pharma Co N.V. (NAMS) | $22.5M | — | — | $3.03B |
| DarioHealth Corp. (DRIO) | $22.4M | — | — | $66.3M |
| Lifeward Ltd. (LFWD) | $22.0M | -90.4% | — | $21.1M |
| Alector, Inc. (ALEC) | $21.0M | — | — | $252.3M |
| Charlie's Holdings, Inc. (CHUC) | $20.9M | 21.5% | 11.0× | $61.7M |
| CASI Pharmaceuticals, Inc. (CASIF) | $20.7M | — | — | $2.7M |
| Jin Medical International Ltd. (ZJYL) | $20.7M | 5.8% | 11.7× | $174.7M |
| SCYNEXIS INC (SCYX) | $20.6M | -41.8% | — | $53.6M |
| Evofem Biosciences, Inc. (EVFM) | $20.2M | 1.9% | — | $1.1M |
| Spectral AI, Inc. (MDAI) | $19.6M | -38.5% | — | $50.5M |
| Sonoma Pharmaceuticals, Inc. (SNOA) | $19.5M | -16.3% | — | $6.3M |
| Sol-Gel Technologies Ltd. (SLGL) | $19.4M | -31.6% | — | $225.3M |
| PRECISION OPTICS CORPORATION, INC. (POCI) | $19.1M | -30.3% | — | $48.2M |
| LENZ Therapeutics, Inc. (LENZ) | $19.1M | — | — | $160.6M |
| QT IMAGING HOLDINGS, INC. (QTI) | $18.9M | — | — | $45.2M |
| NEPHROS INC (NEPH) | $18.8M | 6.4% | 28.4× | $49.4M |
| Bon Natural Life Ltd (BON) | $18.7M | -10.7% | — | $12.0M |
| OmniAb, Inc. (OABIW) | $18.7M | — | — | — |
| Marpai, Inc. (MRAI) | $18.1M | -91.5% | — | $60.9M |
| Universe Pharmaceuticals INC (UPC) | $17.9M | -20.6% | — | $3.3M |
| Birchtech Corp. (BCHT) | $17.6M | -17.2% | — | $33.7M |
| Vivos Therapeutics, Inc. (VVOS) | $17.4M | — | — | $4.5M |
| Pelthos Therapeutics Inc. (PTHS) | $16.8M | — | — | $94.7M |
| Zhengye Biotechnology Holding Ltd (ZYBT) | $16.6M | -60.0% | — | $82.0M |
| Seer, Inc. (SEER) | $16.6M | — | — | $109.6M |
| FOXO TECHNOLOGIES INC. (FOXO) | $16.4M | -75.9% | — | $149,230 |
| Profound Medical Corp. (PROF) | $16.1M | — | — | $250.2M |
| uniQure N.V. (QURE) | $16.1M | — | — | $3.38B |
| BIOTRICITY INC. (BTCY) | $16.0M | -15.0% | — | $2.4M |
| Neuphoria Therapeutics Inc. (NEUP) | $15.6M | -2.4% | — | $20.3M |
| Relay Therapeutics, Inc. (RLAY) | $15.4M | — | — | $4.11B |
| ALLURION TECHNOLOGIES, INC. (ALUR) | $15.2M | — | — | $1.4M |
| VSEE HEALTH, INC. (VSEE) | $14.6M | — | — | $850,197 |
| Opus Genetics, Inc. (IRD) | $14.2M | — | — | $320.3M |
| Arbutus Biopharma Corp (ABUS) | $14.1M | — | — | $1.01B |
| Pyxis Oncology, Inc. (PYXS) | $13.9M | — | — | $269.4M |
| CV Sciences, Inc. (CVSI) | $13.8M | -6.9% | — | $4.5M |
| Lineage Cell Therapeutics, Inc. (LCTX) | $13.6M | — | — | $280.7M |
| Hyperfine, Inc. (HYPR) | $13.6M | — | — | $86.0M |
| CapsoVision, Inc (CV) | $13.6M | — | — | $303.3M |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | $13.1M | — | — | $233.1M |
| Nano-X Imaging Ltd. (NNOX) | $13.0M | — | — | $65.2M |
| Evommune, Inc. (EVMN) | $13.0M | — | — | $480.1M |
| Emmaus Life Sciences, Inc. (EMMA) | $12.5M | -60.2% | — | $3.6M |
| ELUTIA INC. (ELUT) | $12.3M | — | 1.0× | $38.1M |
| Prelude Therapeutics Inc (PRLD) | $12.1M | — | — | $436.5M |
| ESCALON MEDICAL CORP (ESMC) | $12.0M | 0.9% | 1.6× | $1.4M |
| Cardiff Lexington Corp (CDIX) | $11.5M | -47.7% | — | $3.9M |
| Jaguar Health, Inc. (JAGX) | $11.5M | — | — | $4.2M |
| LogicMark, Inc. (LGMK) | $11.4M | -65.4% | — | $1.1M |
| NEXGEL, INC. (NXGL) | $11.4M | -26.3% | — | $3.4M |
| Caribou Biosciences, Inc. (CRBU) | $11.2M | — | — | $176.9M |
| CRESCENT BIOPHARMA, INC. (CBIO) | $10.8M | — | — | $659.7M |
| TScan Therapeutics, Inc. (TCRX) | $10.3M | — | — | $45.2M |
| Alpha Cognition Inc. (ACOG) | $10.2M | — | — | $201.9M |
| Janux Therapeutics, Inc. (JANX) | $10.0M | — | — | $1.10B |
| Zenas BioPharma, Inc. (ZBIO) | $10.0M | — | — | $2.04B |
| WORK Medical Technology Group LTD (WOK) | $9.8M | -10.9% | — | $9.9M |
| Taysha Gene Therapies, Inc. (TSHA) | $9.8M | — | — | $1.88B |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | $9.7M | — | — | $479.0M |
| CURIS INC (CRIS) | $9.4M | -80.3% | — | $3.6M |
| Aspira Women's Health Inc. (AWHL) | $9.2M | — | — | $12.1M |
| Roivant Sciences Ltd. (ROIV) | $8.3M | — | — | $24.93B |
| Aclaris Therapeutics, Inc. (ACRS) | $7.8M | — | — | $884.7M |
| Adagene Inc. (ADAG) | $7.7M | — | — | $235.7M |
| Whitehawk Therapeutics, Inc. (WHWK) | $7.1M | — | — | $263.4M |
| Immunome Inc. (IMNM) | $6.9M | — | — | $3.13B |
| FATE THERAPEUTICS INC (FATE) | $6.6M | — | — | $304.3M |
| KYNTRA BIO, INC. (KYNB) | $6.4M | — | — | $32.5M |
| DBV Technologies S.A. (DBVT) | $5.6M | — | — | $850.9M |
| SCIENTIFIC INDUSTRIES INC (SCND) | $5.1M | -24.1% | — | $9.8M |
| NewGenIvf Group Ltd (NIVF) | $4.7M | — | — | $2.8M |
| ProPhase Labs, Inc. (PRPH) | $4.3M | — | — | $311,851 |
| CRISPR Therapeutics AG (CRSP) | $3.5M | — | — | $5.51B |
| Surrozen, Inc./DE (SRZN) | $3.5M | — | — | $263.5M |
| Cartesian Therapeutics, Inc. (RNAC) | $2.8M | — | — | $290.5M |
| CollPlant Biotechnologies Ltd (CLGN) | $2.4M | — | — | $5.5M |
| Lipocine Inc. (LPCN) | $2.0M | — | — | $17.9M |
| Silence Therapeutics plc (SLN) | $559,000 | — | — | $834.1M |
| Mereo BioPharma Group plc (MREO) | $500,000 | — | — | $40.3M |
| Connect Biopharma Holdings Ltd (CNTB) | $64,000 | — | — | $146.7M |
| Amylyx Pharmaceuticals, Inc. (AMLX) | $0 | — | — | $3.77B |
| Artiva Biotherapeutics, Inc. (ARTV) | $0 | — | — | $551.5M |
| Barinthus Biotherapeutics plc. (BRNS) | $0 | — | — | $29.9M |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | $0 | — | — | $544.2M |
| Denali Therapeutics Inc. (DNLI) | $0 | — | — | $3.80B |
| Fulcrum Therapeutics, Inc. (FULC) | $0 | — | — | $293.7M |
| KIORA PHARMACEUTICALS INC (KPRX) | $0 | — | — | $11.6M |
| Lite Strategy, Inc. (LITS) | $0 | — | — | $34.0M |
| Revolution Medicines, Inc. (RVMD) | $0 | — | — | $44.98B |
| SPRUCE BIOSCIENCES, INC. (SPRB) | $0 | — | — | $174.7M |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | $0 | — | — | $359.8M |
| Contineum Therapeutics, Inc. (CTNM) | — | — | — | $622.6M |
| Equillium, Inc. (EQ) | — | — | — | $155.3M |
| Maze Therapeutics, Inc. (MAZE) | — | — | — | $1.59B |
| PALVELLA THERAPEUTICS, INC. (PVLA) | — | — | — | $2.16B |
| Stablecoin Development Corp (SDEV) | — | — | — | $47.3M |
| Tvardi Therapeutics, Inc. (TVRD) | — | — | — | $24.3M |
| VERU INC. (VERU) | — | — | — | $44.8M |
